Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Emerging therapeutic strategies in COPD
Kesavan S Babu1, Jaymin B Morjaria2
1Dept of Respiratory Medicine, Queen Alexandra Hospital, Southwick Road, Cosham, Portsmouth PO6 3LY, UK.
Newer inhaled therapies and emerging biological treatments are expanding options for managing chronic obstructive pulmonary disease (COPD). Future COPD management may include novel interventions alongside innovative inhaled medications.
Area of Science:
- Pulmonology and Respiratory Medicine
- Pharmacology and Drug Development
Background:
- Chronic obstructive pulmonary disease (COPD) management is evolving with new therapeutic options.
- Current therapies include inhaled corticosteroid (ICS), long-acting β2 agonists (LABAs), and long-acting muscarinic antagonists (LAMAs).
Purpose of the Study:
- To review ongoing Phase II clinical studies in COPD patients.
- To explore the potential of biological and immunomodulatory therapies in COPD.
- To discuss future directions in COPD treatment.
Main Methods:
- Review of Phase II clinical trial data for COPD.
- Analysis of emerging biological and immunomodulatory treatment strategies.
- Assessment of innovative inhaled therapies.
Main Results:
- Phase II studies are exploring novel inhaled medications and devices.
- Biological and immunomodulatory therapies show promise for COPD management.
- A wider range of treatment options is becoming available for patients and physicians.
Conclusions:
- The landscape of COPD management is rapidly advancing.
- Future COPD treatments will likely involve a combination of innovative inhaled therapies and novel interventional strategies.
- Increased understanding of COPD pathogenesis fuels the development of targeted therapies.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-I: Introduction
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

